Bayesian Capital Management, LP Arcturus Therapeutics Holdings Inc. Transaction History

Bayesian Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$24.35 - $44.39 $228,890 - $417,266	9,400 New	9,400 $228,000
Q1 2023 May 15, 2023	BUY	$14.72 - $23.97 $139,825 - $227,691	9,499 New	9,499 $227,000
Q3 2022 Nov 14, 2022	BUY	$13.05 - $22.13 $148,756 - $252,259	11,399 New	11,399 $169,000
Q2 2022 Aug 15, 2022	SELL	$12.26 - $31.17 $101,758 - $258,711	-8,300 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$17.64 - $39.57 $146,412 - $328,431	8,300 New	8,300 $224,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.